From Cause to Cure: A Comprehensive Review on Epidemiology, Pathophysiology, and Management of Peptic Ulcer Disease
Abstract
A common gastrointestinal condition known as peptic ulcer disease (PUD) is marked by ulceration of the stomach and duodenal mucosa due to an imbalance between mucosal defensive and aggressive stimuli. PUD continues to be a major global health burden despite advancements in diagnosis as well as treatment, which results in major complications like perforation, gastrointestinal bleeding, and obstruction. Helicobacter pylori (H. pylori)infection and Non-steroidal anti-inflammatory drug (NSAID) use remain the main underlying causes, but genetics, lifestyle, physiological factors, and environmental factors may also play a role. Dysfunction of mucosal defence, increased acid and pepsin activity, decreased bicarbonate and mucus secretion, inflammation, oxidative stress and alteration in stomach mucosal blood flow are all aspects of the pathogenesis of PUD. With a focus on the basic pathophysiological mechanism behind PUD, this review provides a summary of the disease’s epidemiology and major risk factors. Mucosal protective medicines, proton pump inhibitors, and histamine H2-receptor antagonists. H.pylori eradication regimens and the management of NSAID-associated ulcers are some of the current diagnostic and therapeutic methods that are covered. Additionally, emphasized are emerging therapy approaches and preventive strategies are emphasized. Improved clinical outcomes, early diagnosis, and the prevention of coexisting conditions can all be made possible by a greater awareness of the intricate processes underlying PUD.
Keywords: Duodenal ulcer; Gastric ulcer; Helicobacter pylori; NSAIDs; Proton pump inhibitor; Peptic ulcer disease
Keywords:
Duodenal ulcer, Gastric ulcer, Helicobacter pylori, NSAIDs, Proton pump inhibitor, Peptic ulcer diseaseDOI
https://doi.org/10.22270/jddt.v16i11.8060References
1. Narayanan M, Reddy KM, Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Missouri medicine. 2018 May;115(3):219.
2. Guerra-Valle M, Orellana-Palma P, Petzold G. Plant-based polyphenols: anti-Helicobacter pylori effect and improvement of gut microbiota. Antioxidants. 2022 Jan 4;11(1):109. https://doi.org/10.3390/antiox11010109 PMCid:PMC8772845
3. Rolig AS, Shanks J, Carter JE, Ottemann KM. Helicobacter pylori requires TlpD-driven chemotaxis to proliferate in the antrum. Infection and immunity. 2012 Oct;80(10):3713-20. https://doi.org/10.1128/IAI.00407-12 PMCid:PMC3457577
4. Hajimahmoodi M, Shams-Ardakani M, Saniee P, Siavoshi F, Mehrabani M, Hosseinzadeh H, Foroumadi P, Safavi M, Khanavi M, Akbarzadeh T, Shafiee A. In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Natural Product Research. 2011 Jul 1;25(11):1059-66. https://doi.org/10.1080/14786419.2010.501763
5. Danilo CO, Leanza S. A review on treatment of perforated peptic ulcer by minimally invasive techniques. Maedica. 2022 Sep;17(3):692. https://doi.org/10.26574/maedica.2022.17.3.692
6. Jia X, He Y, Li L, Xu D. Pharmacological targeting of gastric mucosal barrier with traditional Chinese medications for repairing gastric mucosal injury. Frontiers in Pharmacology. 2023 Jun 8;14:1091530. https://doi.org/10.3389/fphar.2023.1091530 PMCid:PMC10285076
7. Wang W, Jiang W, Zhu S, Sun X, Li P, Liu K, Liu H, Gu J, Zhang S. Assessment of prevalence and risk factors of helicobacter pylori infection in an oilfield Community in Hebei, China. BMC gastroenterology. 2019 Nov 14;19(1):186. https://doi.org/10.1186/s12876-019-1108-8 PMCid:PMC6857281
8. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM. Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report. Gut. 2012 May;61(5):646-64. https://doi.org/10.1136/gutjnl-2012-302084
9. Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P, Cochrane Upper GI and Pancreatic Diseases Group. Eradication therapy for peptic ulcer disease in Helicobacter pylori‐positive people. Cochrane Database of Systematic Reviews. 1996 Sep 1;2016(4). https://doi.org/10.1002/14651858.CD003840.pub5
10. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Critical care medicine. 1999 Dec;27(12):2812-7. https://doi.org/10.1097/00003246-199912000-00034
11. Musumba, C., Jorgensen, A., Sutton, L., Van Eker, D., Moorcroft, J., Hopkins, M., Pritchard, D.M. and Pirmohamed, M., 2012. The relative contribution of NSAIDs and H elicobacter pylori to the aetiology of endoscopically‐diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Alimentary pharmacology & therapeutics, 36(1), pp.48-56. https://doi.org/10.1111/j.1365-2036.2012.05118.x
12. Almadi MA, Lu Y, Alali AA, Barkun AN. Peptic ulcer disease. The Lancet. 2024 Jul 6;404(10447):68-81. https://doi.org/10.1016/S0140-6736(24)00155-7
13. Ford AC, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database of Systematic Reviews. 2005(2). https://doi.org/10.1002/14651858.CD003840.pub4
14. Jaswanth K, Kumar K, Venkatesh P. A review on peptic ulcer. UPI Journal of Pharmaceutical, Medical and Health Sciences. 2022 Jan 29:19-26. https://doi.org/10.37022/jpmhs.v5i1.73
15. Søreide K, Thorsen K, Harrison EM, Bingener J, Møller MH, Ohene-Yeboah M, Søreide JA. Perforated peptic ulcer. The Lancet. 2015 Sep 26;386(10000):1288-98. https://doi.org/10.1016/S0140-6736(15)00276-7
16. Lanas A, García‐Rodríguez LA, Polo‐Tomás M, Ponce M, Quintero E, Perez‐Aisa MA, Gisbert JP, Bujanda L, Castro M, Muñoz M, Del‐Pino MD. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Alimentary pharmacology & therapeutics. 2011 Mar;33(5):585-91. https://doi.org/10.1111/j.1365-2036.2010.04563.x
17. Madhusudhan N. Clinical Study of Gastric Outlet Obstruction (Master’s thesis, Rajiv Gandhi University of Health Sciences (India)).
18. Srivastav Y, Mansoori MF, Hameed A, Hashmi A, Ahmad MI. Condensed statement: Critical framework of the diagnosis along with management of peptic ulcer disease (PUD). Advanced Concepts in Pharmaceutical Research. 2024 Apr 2;8:90-111. https://doi.org/10.9734/bpi/acpr/v8/8357E
19. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008 Jul 1;135(1):41-60. https://doi.org/10.1053/j.gastro.2008.05.030
20. Tsimogiannis D, Oreopoulou V. Classification of phenolic compounds in plants. InPolyphenols in plants 2019 Jan 1 (pp. 263-284). Academic Press. https://doi.org/10.1016/B978-0-12-813768-0.00026-8
21. Aravind SM, Wichienchot S, Tsao R, Ramakrishnan S, Chakkaravarthi SJ. Role of dietary polyphenols on gut microbiota, their metabolites and health benefits. Food research international. 2021 Apr 1;142:110189. https://doi.org/10.1016/j.foodres.2021.110189
22. Jaiswal F, Rai AK, Wal P, Wal A, Singh SP. Peptic ulcer: a review on etiology, pathogenesis and treatment. Asian Journal of Pharmaceutical Education and Research. 2021;10(4):1. https://doi.org/10.38164/AJPER/10.4.2021.1-17
23. Lanas A, Chan FK. Peptic ulcer disease. The Lancet. 2017 Aug 5;390(10094):613-24. https://doi.org/10.1016/S0140-6736(16)32404-7
24. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself?. Physiological reviews. 2008 Oct;88(4):1547-65. https://doi.org/10.1152/physrev.00004.2008
25. Makarewicz M, Drożdż I, Tarko T, Chodak A. The interactions between polyphenols and microorganisms, especially gut microbiota. Antioxidants 2021, 10, 188. Fate of Antioxidants in Gut and Interaction of Gut Metabolites and Gut Microbiota. 2021;157. https://doi.org/10.3390/antiox10020188 PMCid:PMC7911950
26. Anchang MM, Okoyeuzu FC, Okafor JN, Okafor GI. The management of peptic ulcer disease using conventional methods, bioactive compounds and dietotherapy: A review. J Gastroenterol Res Pract. 2024;4(5):1202. https://doi.org/10.52768/jjgastro/1202
27. Peterson WL, Sturdevant RA, Frankl HD, Richardson CT, Isenberg JI, Elashoff JD, Sones JQ, Gross RA, McCallum RW, Fordtran JS. Healing of duodenal ulcer with an antacid regimen. New England Journal of Medicine. 1977 Aug 18;297(7):341-5. https://doi.org/10.1056/NEJM197708182970701
28. Safavi M, Sabourian R, Foroumadi A. Treatment of Helicobacter pylori infection: Current and future insights. World journal of clinical cases. 2016 Jan 16;4(1):5. https://doi.org/10.12998/wjcc.v4.i1.5 PMCid:PMC4714294
29. Saheed S, Oladipo AE, Sunmonu TO, Balogun FO, Ashafa AO. The Purview of Phytotherapy in the Management of Gastric Ulcer. IntechOpen; 2018 Jan 10. https://doi.org/10.5772/intechopen.70007
30. Manu P, Rogozea LM, Sandor V, Dumitraşcu DL. Pharmacological management of peptic ulcer: a century of expert opinions in Cecil Textbook of Medicine. American Journal of Therapeutics. 2021 Aug 17;28(5):e552. https://doi.org/10.1097/MJT.0000000000001439 PMCid:PMC8415507
31. Andrawes M, Andrawes W, Das A, Siau K. Proton pump inhibitors (PPIs)-An evidence-based review of indications, efficacy, harms, and deprescribing. Medicina. 2025 Aug 31;61(9):1569. https://doi.org/10.3390/medicina61091569
32. Divya MK, Meera N, Raghavamenon AC, Babu TD. Anti-inflammatory and gastro-protective effects of Apodytesdimidiata. South African Journal of Botany. 2017 Jan 1;108:223-8. https://doi.org/10.1016/j.sajb.2016.10.020
33. Golbabapour S, Hajrezaie M, Hassandarvish P, Abdul Majid N, Hadi AH, Nordin N, Abdulla MA. Acute toxicity and gastroprotective role of M. pruriens in ethanol‐induced gastric mucosal injuries in rats. BioMed Research International. 2013;2013(1):974185. https://doi.org/10.1155/2013/974185
34. Mohammed Ali AM, Abd-Elgwwad SK, Hasan RA, Abd-Elgalil MM. Trio-clar versus portulacaoleracea and/or foeniculumvulgare extracts on induced gastric ulcer in adult female albino rats. A histological study. Egyptian Journal of Histology. 2020 Dec 1;43(4):1008-33. https://doi.org/10.21608/ejh.2020.24868.1256
35. Okonkwo CO, Maduka SO, Onyebuchi I, Okwuonu I. Antiulcerative Properties of Cabbage Juice on Indomethacin Induced Ulcer in Albino Rats. Middle European Scientific Bulletin. 2021;13.
36. Rahim NA, Hassandarvish P, Golbabapour S, Ismail S, Tayyab S, Abdulla MA. Gastroprotective Effect of Ethanolic Extract of Curcuma xanthorrhiza Leaf against Ethanol‐Induced Gastric Mucosal Lesions in Sprague-Dawley Rats. BioMed research international. 2014;2014(1):416409. https://doi.org/10.1155/2014/416409 PMCid:PMC3982285
37. Panda V, Suresh S. Gastro-protective effects of the phenolic acids of Macrotyloma uniflorum (horse gram) on experimental gastric ulcer models in rats. Food bioscience. 2015 Dec 1;12:34-46. https://doi.org/10.1016/j.fbio.2015.07.004
38. Kadasah S, Al Eid AS, Alawad SS, Al Shahrani AS, Alruwaihi AS, Elfaki I, Arshaduddin M. Gastro protecting influence of Topiramate in ethanol produced gastric ulcers in rats. Toxicology reports. 2021 Jan 1;8:1031-9. https://doi.org/10.1016/j.toxrep.2021.05.004
39. Kato N, Mashita Y, Kato S, Mitsufuji S, Yoshikawa T, Takeuchi K. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism. Digestive diseases and sciences. 2009 Nov;54(11):2346-56. https://doi.org/10.1007/s10620-008-0646-7
40. Beiranvand M, Bahramikia S. Ameliorating and protective effects mesalazine on ethanol-induced gastric ulcers in experimental rats. European Journal of Pharmacology. 2020 Dec 5;888:173573. https://doi.org/10.1016/j.ejphar.2020.173573
41. Moawad H, El Awdan SA, Sallam NA, El-Eraky WI, Alkhawlani MA. Gastroprotective effect of cilostazol against ethanol-and pylorus ligation-induced gastric lesions in rats. Naunyn-Schmiedeberg’s archives of pharmacology. 2019 Dec;392(12):1605-16. https://doi.org/10.1007/s00210-019-01699-y
42. Soliman NA, Zineldeen DH, Katary MA, Ali DA. N-acetylcysteine a possible protector against indomethacin-induced peptic ulcer: crosstalk between antioxidant, anti-inflammatory, and antiapoptotic mechanisms. Canadian journal of physiology and pharmacology. 2017;95(4):396-403. https://doi.org/10.1139/cjpp-2016-0442
Published
Abstract Display: 0
PDF Downloads: 0
PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Siddhi Gaur , Hema Negi , Disha Gupta , Zulekha Ali , Neha Yadav , Swati Mittal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.